Thursday, 20 February 2014

Primus Capital invests in the expansion of Maven7

Official press release on the recent happenings in our company's life:

Budapest, Hungary – Boston, MA
Primus Capital Fund Management Ltd. is investing more than 170 million forints (approx. 750,000 US dollars) acquiring a minority stake in Maven Seven Network Research Ltd. (Maven7), a provider of unique network research-based analyses and services. Through the capital investment, the 4-year-old company will further develop its online diagnostic tool, OrgMapper, and take it to Western European and overseas markets. It will also strengthen the sales activities of its US subsidiary and further develop its network analysis services for the media and pharmaceutical sectors.

Maven7 applies the latest results and innovations in network science to the business environment. Among its co-founders are such internationally acclaimed scientists of the discipline as Albert-László Barabási (Northeastern and Harvard Universities) and Tamás Vicsek (Hungarian Academy of Sciences, ELTE), who rightfully ensure the company's academic credibility.

Maven7 supports business decisions by transforming large amounts of hard-to-interpret data into actionable business intelligence.

The company's online Software as a Service (SaaS) platform, OrgMapper, allows its users, primarily in the business consulting sector, to conduct analyses in organizational development, the media, and the pharmaceutical industry, on the basis of which consultancies can provide M&A advisory, change management and other services to their customers.

Maven7 is the 10th investment of Primus Capital. "International competitiveness and execution built on the expertise of Central European physicists and engineers – this is the strategy of Maven7 and Primus Capital. We are proud to be working with such a fast-growing company and a team of extremely talented professionals in order to achieve international growth", added Zoltán Bruckner, investment director at Primus Capital.

1 comment: